Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Sorrento Announces Drilling Contract & Receives Permit to Drill Bottom Brook Project (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News RenovoRx Inc RNXT

Healthcare Biotechnology
RenovoRx, Inc., a clinical-stage biopharmaceutical company, engages in the developing of targeted combination therapies to enhance therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is chemotherapy gemcitabine, which is provided through RenovoCath that is in Phase III clinical trials for the treatment of locally advanced pancreatic cancer. RenovoRx, Inc... see more

Current News (NDAQ:RNXT)

RenovoRx to Participate in AlphaNorth Capital Event, January 16-18, 2026

GlobeNewswire 1 day ago

RenovoRx To Announce Promising New Clinical Data Using its TAMP(TM) Therapy Platform in an Abstract to be Presented at ASCO GI 2026

GlobeNewswire 7 days ago

RenovoRx Announces Acceptance of Clinical Data Abstract at the ASCO Gastrointestinal Cancers Symposium 2026

GlobeNewswire December 11, 2025

RenovoRx CEO Shaun Bagai to Present at iAccess Alpha Virtual Best Ideas Winter Investment Conference 2025 on December 9th

GlobeNewswire December 1, 2025

RenovoRx CEO Shaun Bagai to Present at the Alliance Global Partners Emerging AgBiotech/Bio-Solutions Virtual Showcase on November 20th

GlobeNewswire November 19, 2025

RenovoRx Reports Third Quarter 2025 Financial Results, Including Approximately $900,000 in Year-to-Date Revenue, and Provides Business Update

GlobeNewswire November 13, 2025

RenovoRx Strengthens Scientific Advisory Board (SAB) with Pancreatic Cancer Expert Timothy Donahue, MD

GlobeNewswire November 6, 2025

RenovoRx CEO Shaun Bagai to Participate at the Canaccord Genuity MedTech, Diagnostics & Digital Health & Services Forum on November 20th

GlobeNewswire November 4, 2025

RenovoRx to Host Third Quarter 2025 Financial Results and Business Highlights Conference Call on November 13th at 4:30 p.m. ET

GlobeNewswire October 27, 2025
View More News ››

Opinion & Analysis (NDAQ:RNXT)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:RNXT)

An Undervalued Biotech Showing Promise

An Undervalued Biotech Showing Promise https://10xalerts.com/an-undervalued-biotech-showing-promise/
Mathew177 - October 25, 2024

RenovoRx, Inc. (RNXT): Pioneering Precision Oncology with Pr

http://beyondspx.com/2024/08/01/renovorx-inc-rnxt-pioneering-precision-oncology-with-promising-clinical-results/
MikeTester - August 1, 2024

RenovoRx’s Breakthroughs in Targeted Cancer Treatments

RenovoRx’s Breakthroughs in Targeted Cancer Treatments (NASDAQ: RNXT) ...
ElliotGH - July 16, 2024

RenovoRx Announces Acceptance for Publication

RenovoRx Announces Acceptance for Publication in the International Peer-Reviewed Journal, The...
Mathew177 - July 9, 2024

University of Nebraska Medical Center Launches Patient

University of Nebraska Medical Center Launches Patient Enrollment for RenovoRxs Pivotal Phase III TIGeR-PaC Clinical Trial (NASDAQ: RNXT)...
Mathew177 - June 26, 2024

Ascendiant Capital highlights cancer therapy, sees potential

Ascendiant Capital highlights cancer therapy, sees potential on RenovoRx stock (NASDAQ: RNXT) ...
ElliotGH - June 17, 2024
View more Bullboard ››

Sorrento Resources Ltd.

Sorrento Resources Ltd.

Sorrento is engaged in acquisition, exploration, and development of mineral property assets in Canada. Sorrento’s objective ...
View More »

Podcasts